News|Articles|July 28, 2026

How Should You Respond to FDA 483 Observations?

Is FDA getting tired of writing warning letters? A new draft guidance shows how companies should respond to Form 483 observations.

In March, the Agency published a draft guidance on Responding to FDA Form 483 Observations.1 We will discuss it from a laboratory perspective, covering:

Related to this article

LC–MS/MS Tracks Stress Hormones in Burnout Study
A three-year study of medical students and doctors in training tracked burnout symptoms alongside inflammation markers and morning cortisol and cortisone levels in saliva, measured by liquid chromatography–tandem mass spectrometry (LC–MS/MS), to better understand the biology of burnout.